Literature DB >> 9862861

Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats.

I Shimizu1, Y R Ma, Y Mizobuchi, F Liu, T Miura, Y Nakai, M Yasuda, M Shiba, T Horie, S Amagaya, N Kawada, H Hori, S Ito.   

Abstract

It has been shown that lipid peroxidation is associated with hepatic fibrosis and stellate cell activation. Sho-saiko-to (TJ-9) is an herbal medicine, which is commonly used to treat chronic hepatitis in Japan, although the mechanism by which TJ-9 protects against hepatic fibrosis is not known. As a result, we assayed the preventive and therapeutic effects of TJ-9 on experimental hepatic fibrosis, induced in rats by dimethylnitrosamine (DMN) or pig serum (PS), and on rat stellate cells and hepatocytes in primary culture, and assessed the antioxidative activities and the active components of TJ-9. Male Wistar rats were given a single intraperitoneal injection of 40 mg/kg DMN or 0.5 mL PS twice weekly for 10 weeks. In each model, rats were fed a basal diet throughout, or the same diet, which also contained 1.5% TJ-9, for 2 weeks before treatment or for the last 2 weeks of treatment. TJ-9 suppressed the induction of hepatic fibrosis, increased hepatic retinoids, and reduced the hepatic levels of collagen and malondialdehyde (MDA), a production of lipid peroxidation. Immunohistochemical examination showed that TJ-9 reduced the deposition of type I collagen and the number of alpha-smooth muscle actin (alpha-SMA) positive-stellate cells in the liver and inhibited, not only lipid peroxidation in cultured rat hepatocytes that were undergoing oxidative stress, but also the production of type I collagen, alpha-SMA expression, cell proliferation, and oxidative burst in cultured rat stellate cells. In addition, TJ-9 inhibited Fe2+/adenosine 5'-diphosphate-induced lipid peroxidation in rat liver mitochondria in a dose-dependent manner and showed radical scavenging activity. Among the active components of TJ-9, baicalin and baicalein were found to be mainly responsible for the antioxidative activity. These findings suggest that Sho-saiko-to (TJ-9) functions as a potent antifibrosuppressant by inhibition of lipid peroxidation in hepatocytes and stellate cells in vivo.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9862861     DOI: 10.1002/hep.510290108

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  34 in total

1.  Effects of glycyrrhetinic acid on collagen metabolism of hepatic stellate cells at different stages of liver fibrosis in rats.

Authors:  J Y Wang; Q S Zhang; J S Guo; M Y Hu
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

2.  Semi-quantitative analysis of cytokine mRNA expression induced by the herbal medicine Sho-saiko-to (TJ-9) using a Gel Doc system.

Authors:  X X Huang; M Yamashiki; K Nakatani; T Nobori; A Mase
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

Review 3.  Current and future anti-fibrotic therapies for chronic liver disease.

Authors:  Don C Rockey
Journal:  Clin Liver Dis       Date:  2008-11       Impact factor: 6.126

4.  Effects of total glucosides of peony on immunological hepatic fibrosis in rats.

Authors:  Hua Wang; Wei Wei; Ni-Ping Wang; Cheng-Yi Wu; Shang-Xue Yan; Li Yue; Ling-Ling Zhang; Shu-Yun Xu
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

5.  Effects of Chinese traditional compound, JinSanE, on expression of TGF-beta1 and TGF-beta1 type II receptor mRNA, Smad3 and Smad7 on experimental hepatic fibrosis in vivo.

Authors:  Shi-Ling Song; Zuo-Jiong Gong; Quan-Rong Zhang; Tuan-Xin Huang
Journal:  World J Gastroenterol       Date:  2005-04-21       Impact factor: 5.742

Review 6.  Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.

Authors:  Koji Miyanishi; Toshifumi Hoki; Shingo Tanaka; Junji Kato
Journal:  World J Hepatol       Date:  2015-03-27

Review 7.  Optimal management for alcoholic liver disease: Conventional medications, natural therapy or combination?

Authors:  Moon-Sun Kim; Madeleine Ong; Xianqin Qu
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

8.  Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction.

Authors:  Göksel Sener; A Ozer Sehirli; Hale Z Toklu; Meral Yuksel; Feriha Ercan; Nursal Gedik
Journal:  Pediatr Surg Int       Date:  2007-01-10       Impact factor: 1.827

9.  The Dimethylnitrosamine Induced Liver Fibrosis Model in the Rat.

Authors:  Kum Fai Chooi; Dinesh Babu Kuppan Rajendran; Siew Siang Gary Phang; Han Hui Alden Toh
Journal:  J Vis Exp       Date:  2016-06-17       Impact factor: 1.355

10.  Inhibitory effects of armepavine against hepatic fibrosis in rats.

Authors:  Ting-Chun Weng; Chien-Chang Shen; Yung-Tsung Chiu; Yun-Lian Lin; Cheng-Deng Kuo; Yi-Tsau Huang
Journal:  J Biomed Sci       Date:  2009-09-02       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.